Culturally Adapted Contingency Management
ConditionStimulant Use Disorders
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorYale University
About this trial
The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.
Eligibility criteria
Qualifiers
participants must self-identify as Black/African American
DSM-5 diagnosis of stimulant use disorder in the past month (30 days)
Disqualifiers
individuals who are intoxicated or otherwise unable to provide consent
Trial design
Treatments tested in this trial
- Cultually Adapted Contingency Management (CM)
- Basic Contingency Management (CM)
Treatment groups
70 Participants
are divided into 3 treatment groupsSponsors and collaborators
Yale University
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov